Cassava Sciences’ stock craters after Alzheimer’s disease trial fails to meet its goals

The biotech company said it will discontinue a second trial but will still offer a full analysis of the data.

Business - MarketWatch - 2 days ago

Sage Therapeutics to end development of key therapy after a third trial failure

It was the third failed trial for the therapy, called dalzanemdor, which also failed to meet its goals in a Phase 2 trial as a treatment for mild cognitive impairment and mild dementia in ...

Business - MarketWatch - November 20

Cannabis stocks crater as Florida fails to garner needed votes for adult use

North Dakota and South Dakota also failed in their efforts to legalize cannabis for recreational use, while a medical measure passed in Nebraska.

Business - MarketWatch - November 6

Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results

Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.

Business - The New York Times - Yesterday

Bayer’s stock slumps after warning on crop-sciences unit

Bayer’s stock slumped on Tuesday as the German giant gave a profit warning on agricultural demand.

Business - MarketWatch - November 12

Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug

Biogen’s stock rose 1% Thursday, after Europe’s pharmaceutical regulator issued a positive opinion on the Alzheimer’s disease drug that the company developed with Japanese partner Eisai — reversing ...

Business - MarketWatch - November 14

Biogen’s stock hit by soft sales of Alzheimer’s treatment

“We continue to see momentum with ongoing product launches and we are increasingly excited about the potential of our pipeline,” the company’s CEO said.

Business - MarketWatch - October 30

Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial

The stock, which enjoys the unusual position of having all buy ratings from the 13 analysts offering coverage on FactSet, has been on a tear this year, gaining 270% to date in 2024.

Business - MarketWatch - November 4

‘We’re living in uncertainty’: My sister has Alzheimer’s disease. How do I know the right time to take control of her finances?

“My eldest sister has asked me to take on her power of attorney for her, and together we met with her attorney.”

Business - MarketWatch - Yesterday

Linde falls after its guidance fails to wow the market. We've seen this movie before

Shares of the industrial gas supplier dropped around 3% in a down market.

Business - CNBC - October 31

PayPal beat big on a profit metric, but here’s why its stock is falling

PayPal’s fourth-quarter revenue view came in below expectations. The company said it’s focusing on “profitable growth.”

Business - MarketWatch - October 29

Boeing’s stock fails to hold gains after strike ends, but bonds are holding up

Spreads on Boeing’s outstanding bonds are moving tighter on the day after workers voted to end a 53-day strike.

Business - MarketWatch - November 5

Bristol Myers Squibb’s stock soars after rival AbbVie reports disappointing schizophrenia-drug trial

Bristol Myers Squibb Co. shares surged 12.5% Monday after rival AbbVie Inc. reported disappointing results from the trial of a new schizophrenia drug.

Business - MarketWatch - November 11

Science Says 3 Strategies Will Help You Achieve Your Big Goals and Live Your Best Life

The research also shows that you need help to achieve your big goals.

Business - Inc. - 6 hours ago

2 Good 2 Bad: Timber's bizarre throw-in fail and a goal of the month?

A bizarre throw in from Arsenal's Jurrien Timber, and a goal of the season contender from Brentford's Yoane Wissa feature in this week's '2 Good, 2 Bad' from Match of the Day 2.

23andMe’s stock falls after company says there’s substantial doubt it can stay in business

Shares of 23andMe fell 4% Tuesday after the DNA-testing company reported its latest quarterly loss and included “going concern” language in its financial statements, shedding gains made late Monday ...

Business - MarketWatch - November 12

Tesla should sell its stock after the big post-election run up, analyst says

Tesla should take advantage of its stock’s post-election surge to raise capital by selling shares, a Jefferies analyst says.

Business - MarketWatch - November 14

Immigration cuts: Why prime ministers keep failing to meet their targets

Promises on net migration have been made for 15 years - but few kept them

Japanese automaker Nissan cuts 9,000 jobs as its vehicles fail to sell

Nissan is reporting a loss for the latest fiscal quarter as its vehicle sales sank while costs and inventory ballooned

World - ABC News - November 7

Why the stock market failed to see that Trump would win the presidential election

The Dow’s strong gain this year favored the Democrats and Kamala Harris. But Wall Street is increasingly disconnected from Main Street.

Business - MarketWatch - November 8

What Really Happens to a Founder After They Fail

Everyone wants you to embrace failure, but they rarely stick around for the fall.

Business - Inc. - November 15

At COP29, Tourism Gets Its Day. How Has It Fared With Climate Goals?

The tourism industry will be officially recognized at COP29 on Wednesday. Industry leaders signed a climate accord in 2021 to make travel more sustainable, but the results so far are meager.

Business - The New York Times - November 19

Israeli government failed to protect citizens in Oct. 7 attacks, civilian-led probe finds

The Israeli government failed in its “duty to protect its citizens” in the lead-up to and during the Oct. 7, attacks, an Israeli civilian report said Tuesday.

Merck says blockbuster cancer drug met main goals in trial of new under-the-skin formulation

The news may help Merck retain sales of Keytruda, which is the world’s best-selling drug.

Business - MarketWatch - November 19

US will not stop military aid to Israel over approach to Gaza

Washington satisfied by country’s aid efforts despite humanitarian groups warning people are being ‘starved’ in enclave

Business - Financial Times - November 12

Maldives recalls its ambassador in Pakistan over unsanctioned meeting with Kabul's envoy

Pakistani officials said on Tuesday they were aware the Maldives government had recalled its ambassador to Pakistan after he met with the Afghan Taliban government’s top diplomat in Islamabad ...

World - ABC News - November 5

Democrats try to force Ethics Committee to release Gaetz report

Bipartisan House Ethics Committee were deadlocked along party lines on whether to release a report on its investigation of Matt Gaetz, Trump's attorney general pick.

Here are our top 5 performing stocks since October's Monthly Meeting

Donald Trump's presidential election victory and the Fed's policy decisions have been front and center since our last monthly gathering.

Business - CNBC - November 14

Alibaba’s stock turns lower as investments to meet AI demand hurt profitability

Alibaba’s stock knee-jerked up after earnings then reversed lower, as revenue missed expectations and ’aggressive’ investments on AI capabilities weighed on profitability.

Business - MarketWatch - November 15

EU braced for blows from all sides in march to meet net zero goals

Critics at home and abroad lash out at demands to cut emissions while the US is unlikely to offer much support

World - Financial Times - November 11

Judge scolds Giuliani for not turning over assets, including car he's driving

Giuliani got a tongue lashing Thursday in federal court after missing a deadline to turn over valuables to two election workers he defamed. He owes the women $148 million in damages.

Student kills eight in mass stabbing in China after failing exams

A 21-year-old former student carried out the attack at a vocational college in the eastern city of Wuxi, police said, after failing exams and being frustrated with low internship pay. Eight people ...

World - The Guardian - November 16

What's next for Biden after Trump transition meeting?

President Biden headed to Peru Thursday for the APEC summit where he is meeting with Chinese President Xi Jinping. This comes after his meeting with President-elect Donald Trump at the White House. ...

Intel books big charges for restructuring, but here’s why its stock is surging

The company says business trends are improving despite ‘noisy’ earnings.

Business - MarketWatch - November 1

Palantir’s stock racks up new bearish call on its ‘unsustainable’ valuation

A Jefferies analyst thinks Palantir’s large base of retail-investor support “is a double-edged sword.”

Business - MarketWatch - November 7

Block offers a glimpse of what to expect next year, but its stock slides

The parent company of Square and the Cash App expects to keep expanding operating margins into 2025.

Business - MarketWatch - November 8

Latest in Cassava Sciences’ stock craters after Alzheimer’s disease trial fails to meet its goals